Drug approvals in Europe

The Life Science Leader has a new article out about the challenges to getting drugs approved in Europe. It can often take years to get a new drug to the market, from finding the right molecule to fully adhering to the regulatory environment.

Some of the challenges laid out by the article include:
- Need for a Transatlantic Regulatory Integration
- Urgent Need for Developing a Sentinel Network for Enhancing Drug Safety Landscape
- Need for Fast-Tracking Framework

The article calls for a global initiative to design and evaluate clinical trials. Read the full article here. What do you think?

Share this article with your social network, just click below to share now!

Share |